Resources

Selected Filters:

Antibodies Clear Filters

Application Notes

Tailored solutions for vaccine development

18 Sept 2023

Application Notes

AAV manufacturing workflow

17 Sept 2023

Application Notes

BOND RX & BOND RXm: Automated chromogenic multiplexing

13 Sept 2023

Application Notes

BOND RX: Automated fluorescent multiplexing

13 Sept 2023

Application Notes

Identifying monoclonal antibodies with Quantum-Si’s next-generation protein sequencing technology

29 Aug 2023

Application Notes

Advance T cell therapies with non-viral CRISPR

22 Aug 2023

Scientific Posters

PD-1: Expanding beyond cancer research

13 Aug 2023

Application Notes

Maximize success in biotherapeutic antibody development

24 Jul 2023

Application Notes

PrismA ELISA kit

18 Jul 2023

Application Notes

Rapid lateral flow tests: Considerations for product development

17 Jul 2023

Resources

Resources Filter

Search

Selected Filters:

Tailored solutions for vaccine development

AAV manufacturing workflow

BOND RX & BOND RXm: Automated chromogenic multiplexing

BOND RX: Automated fluorescent multiplexing

Identifying monoclonal antibodies with Quantum-Si’s next-generation protein sequencing technology

Advance T cell therapies with non-viral CRISPR

PD-1: Expanding beyond cancer research

Maximize success in biotherapeutic antibody development

PrismA ELISA kit

Rapid lateral flow tests: Considerations for product development

Resources

Resources FilterResources Filter

Search

Selected Filters:

Tailored solutions for vaccine development

AAV manufacturing workflow

BOND RX & BOND RXm: Automated chromogenic multiplexing

BOND RX: Automated fluorescent multiplexing

Identifying monoclonal antibodies with Quantum-Si’s next-generation protein sequencing technology

Advance T cell therapies with non-viral CRISPR

PD-1: Expanding beyond cancer research

Maximize success in biotherapeutic antibody development

PrismA ELISA kit

Rapid lateral flow tests: Considerations for product development

Resources Filter